ArticleFrontiers in immunology2023

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Ana Jiménez-Ubieto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.